High-risk groups for alpha-gal sensitization.

alpha-gal sensitization borreliosis tick contact

Journal

Allergologie select
ISSN: 2512-8957
Titre abrégé: Allergol Select
Pays: Germany
ID NLM: 101722686

Informations de publication

Date de publication:
2023
Historique:
received: 03 03 2023
accepted: 27 06 2023
medline: 14 9 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: epublish

Résumé

Tick bite-induced IgE-mediated reactions to the oligosaccharide galactose α-1,3-galactose (alpha-gal) are increasingly recognized. This study investigated alpha-gal sensitization in three groups with different tick bite exposure. Specific IgE antibodies to alpha-gal and total IgE were investigated in 485 patients with Lyme borreliosis with different disease manifestations and compared to a control group of 200 randomly selected patients without increased exposure to tick bites. A group of 232 hunters and forest workers served as a model for multiple tick bites. Specific IgE (sIgE) antibodies to alpha-gal (> 0.1 kU/L) were found in 12.6% of all borreliosis samples compared to the control group with 9% (relative risk 1.4; 95% CI 0.85 - 2.3; not significant (n.s.). The highest prevalence of sIgE to alpha-gal was observed in hunters and forest service employees (22.8%, relative risk 2.5; 95% CI 1.5 - 4.2; p < 0.001). Higher age and elevated total IgE were also associated with alpha-gal sensitization. IgE sensitization to alpha-gal tends to be more frequent in tick-exposed patients with borreliosis than in controls (n.s.). Moreover, hunters and forest workers show an even higher rate of elevated IgE to alpha-gal. Thus, frequent tick contact may result in alpha-gal sensitization. In the area of Munich, the prevalence of alpha-gal sensitization appears lower than in the state of Baden-Württemberg and lower than in the USA, which may be due to the difference in tick species or the frequency of tick exposure. This study could show that alpha-gal sensitization and presumably alpha-gal syndrome does not seem to be a modern problem but existed already more than 30 years ago.

Sections du résumé

BACKGROUND BACKGROUND
Tick bite-induced IgE-mediated reactions to the oligosaccharide galactose α-1,3-galactose (alpha-gal) are increasingly recognized. This study investigated alpha-gal sensitization in three groups with different tick bite exposure.
MATERIALS AND METHODS METHODS
Specific IgE antibodies to alpha-gal and total IgE were investigated in 485 patients with Lyme borreliosis with different disease manifestations and compared to a control group of 200 randomly selected patients without increased exposure to tick bites. A group of 232 hunters and forest workers served as a model for multiple tick bites.
RESULTS RESULTS
Specific IgE (sIgE) antibodies to alpha-gal (> 0.1 kU/L) were found in 12.6% of all borreliosis samples compared to the control group with 9% (relative risk 1.4; 95% CI 0.85 - 2.3; not significant (n.s.). The highest prevalence of sIgE to alpha-gal was observed in hunters and forest service employees (22.8%, relative risk 2.5; 95% CI 1.5 - 4.2; p < 0.001). Higher age and elevated total IgE were also associated with alpha-gal sensitization.
CONCLUSION CONCLUSIONS
IgE sensitization to alpha-gal tends to be more frequent in tick-exposed patients with borreliosis than in controls (n.s.). Moreover, hunters and forest workers show an even higher rate of elevated IgE to alpha-gal. Thus, frequent tick contact may result in alpha-gal sensitization. In the area of Munich, the prevalence of alpha-gal sensitization appears lower than in the state of Baden-Württemberg and lower than in the USA, which may be due to the difference in tick species or the frequency of tick exposure. This study could show that alpha-gal sensitization and presumably alpha-gal syndrome does not seem to be a modern problem but existed already more than 30 years ago.

Identifiants

pubmed: 37705677
doi: 10.5414/ALX02424E
pmc: PMC10495941
doi:

Types de publication

Journal Article

Langues

eng

Pagination

140-148

Informations de copyright

© Dustri-Verlag Dr. K. Feistle.

Déclaration de conflit d'intérêts

TB was investigator for Thermo Fisher Scientific and reports non-financial support (laboratory material and analytical support) from Thermo Fisher Scientific. All other authors report no conflict of interest in relation to this work. Table 1.Borreliosis stage and elevated specific IgE antibodies against alpha-gal with a threshold of > 0.1 kU/L; population at high risk for tick bites divided into forest workers from 1988 and forest service employees, hunters, and members of hunting societies, and patients (acute borreliosis: erythema migrans; chronic borreliosis: acrodermatitis chronica atrophicans). PopulationNumber of patients0,1 – 0.69 CAP 0 – 1 n0.70 – 3.49 CAP 2 n3.50 – 17.49 CAP 3 n17,50 – 49,99 CAP 4 n50.0 – 99.99 CAP 5 n> 100 kU/L CAP 6 nn (% of total)Acute borreliosis3652812200042 (11.5%)Chronic borreliosis120132400019 (15.8%)Total: 61 (12.6%)Forest workers 19885653300112 (21.4%)Forest service employees 2016176238721041 (23.3%)Total 53 (22.8%)Control group2001620000Total 18 (9%)sIgE = specific IgE. Figure 1Prevalence of elevated specific IgE antibodies to alpha-gal in the tested populations. The prevalence of specific IgE to alpha-gal was significantly higher in hunters/forest workers than in borreliosis patients and controls. **p < 0.01, ***p < 0.001. Continuous numerical variables were calculated as medians and interquartile ranges and compared by the non-parametric Mann-Whitney test for independent variables. The Kruskal-Wallis test was applied to compare continuous numerical variables between the groups. Table 2.Comparison of the relative sensitization risk in two tick-exposed populations. Tick bite-exposed groups show different increased relative risk for developing alpha-gal sensitization compared to controls. RR95% CIpBorreliosis group1.40.85 – 2.3(n.s.)Hunters2.51.5 – 4.2p < 0.001RR = relative risk; 95% CI = 95% confidence interval; n.s. = not significant. Figure 2Age distribution among borreliosis patients (a) and control group (b). Specific IgE to alpha-gal > 0.1 kU/L, absolute numbers. An increased sensitization in patients older than 50 years was observed in both groups.

Références

J Allergy Clin Immunol. 2009 Feb;123(2):426-33
pubmed: 19070355
Curr Opin Allergy Clin Immunol. 2013 Aug;13(4):354-9
pubmed: 23743512
Ticks Tick Borne Dis. 2020 Sep;11(5):101506
pubmed: 32723636
J Allergy Clin Immunol Pract. 2020 Jun;8(6):2027-2034.e2
pubmed: 32142962
Immunology. 2013 Sep;140(1):1-11
pubmed: 23578170
PLoS One. 2017 Sep 27;12(9):e0185723
pubmed: 28953957
Ann Allergy Asthma Immunol. 2019 Jun;122(6):598-602
pubmed: 30922956
J Allergy Clin Immunol Pract. 2019 Feb;7(2):685-686
pubmed: 30195008
Curr Allergy Asthma Rep. 2019 Jan 23;19(1):3
pubmed: 30673913
Curr Allergy Asthma Rep. 2017 Jan;17(1):8
pubmed: 28224342
J Allergy Clin Immunol. 2013 Dec;132(6):1431-1434
pubmed: 24094548
Allergy. 2013 Apr;68(4):549-52
pubmed: 23414348
J Allergy Clin Immunol. 2020 Apr;145(4):1061-1071
pubmed: 32057766
Curr Top Microbiol Immunol. 2007;315:289-324
pubmed: 17848069
Allergy. 2017 Oct;72(10):1540-1547
pubmed: 28273338
Asia Pac Allergy. 2015 Jan;5(1):3-16
pubmed: 25653915
Int J Parasitol. 2016 Mar;46(3):213-220
pubmed: 26812026
Clin Exp Allergy. 2016 Feb;46(2):377-80
pubmed: 26450130
J Allergy Clin Immunol. 2014 Jul;134(1):108-15
pubmed: 24656556
J Mol Evol. 2015 Jan;80(1):1-9
pubmed: 25315716
J Allergy Clin Immunol. 2014 Sep;134(3):755-759.e1
pubmed: 25171869
Clin Exp Allergy. 2014 Aug;44(8):1061-8
pubmed: 24750173
N Engl J Med. 2008 Mar 13;358(11):1109-17
pubmed: 18337601
Allergy. 2017 Dec;72(12):2044-2047
pubmed: 29159820
Allergo J Int. 2016;25:55-62
pubmed: 27226951
J Allergy Clin Immunol. 2011 May;127(5):1286-93.e6
pubmed: 21453959

Auteurs

Marie Benders-Guedj (M)

Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Martin Köberle (M)

Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Heidelore Hofmann (H)

Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Tilo Biedermann (T)

Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Ulf Darsow (U)

Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.

Classifications MeSH